Psychedelic compounds are widespread in nature: about 80 fungal species, at least 20 plants and one toad species produce psychoactive molecules, with origins stretching back millions of years. These chemicals can deter predators (for example, the Sonoran Desert toad’s 5‑MeO‑DMT) or possibly attract animals that disperse seeds and spores. Notable natural psychedelics include mescaline (San Pedro, peyote), psilocybin (many mushrooms), ibogaine (Tabernanthe iboga), DMT (chacruna, yopo) and ergot alkaloids from grain fungi. Their cultural, archaeological and medical roles underscore a deep, global relationship between humans and these compounds.
Nature’s Psychedelic Tour: How Evolution Keeps Reinventing Mind‑Altering Molecules
Psychedelic compounds are widespread in nature: about 80 fungal species, at least 20 plants and one toad species produce psychoactive molecules, with origins stretching back millions of years. These chemicals can deter predators (for example, the Sonoran Desert toad’s 5‑MeO‑DMT) or possibly attract animals that disperse seeds and spores. Notable natural psychedelics include mescaline (San Pedro, peyote), psilocybin (many mushrooms), ibogaine (Tabernanthe iboga), DMT (chacruna, yopo) and ergot alkaloids from grain fungi. Their cultural, archaeological and medical roles underscore a deep, global relationship between humans and these compounds.

Nature’s Psychedelic Tour: How Evolution Keeps Reinventing Mind‑Altering Molecules
Evolution has repeatedly produced molecules that alter perception and consciousness: psychedelic compounds are far more widespread in nature than most people realize. Fossil, chemical and ethnobotanical evidence suggests these chemicals have appeared multiple times over evolutionary history, with traces stretching back tens of millions of years. To date, researchers have identified roughly 80 species of fungi, at least 20 plant species and a single vertebrate that synthesize powerful psychoactive molecules—and new producers continue to surface. The structures and effects of these compounds are as diverse as the ecosystems where they occur.
These substances have long cultural, spiritual and medicinal histories: iboga, peyote, ayahuasca, psilocybin mushrooms, cannabis, ethanol and opium figure in rituals and healing practices around the world. Scientists debate why so many organisms make these chemicals; two clear roles emerge from research and observation. First, some compounds act as defenses, deterring herbivores, insects or other predators. Second, in a few cases the chemistry may entice animals, altering behavior in ways that help disperse seeds, spores or vegetative material.
Below is a guided tour of notable ecosystems and the remarkable plants, fungi and animals that produce these mind‑altering molecules—along with brief notes on cultural use, historical evidence and conservation concerns.
San Pedro cactus (Echinopsis pachanoi)
Native to the high‑altitude deserts and valleys of the Andes, the San Pedro cactus contains the psychedelic alkaloid mescaline. When ingested mescaline can cause euphoria, perceptual and visual changes, feelings of connection as well as nausea or anxiety in some users. Archaeological remains from a Peruvian cave indicate consumption of San Pedro as far back as 8,600 B.C., among the oldest direct evidence for mescaline use.
Peyote (Lophophora williamsii)
Peyote is a small, spineless cactus native to parts of Mexico and Texas and is also rich in mescaline. Archaeological specimens from caves in Texas indicate human use around 3,200 B.C. While trace amounts of mescaline occur in other cacti, San Pedro and peyote are notable for naturally high concentrations that produce pronounced effects without extensive refinement. Peyote remains central to several Indigenous religious traditions.
The Sonoran Desert Toad (Incilius alvarius)
Found in the Sonoran Desert of the southwestern United States and northern Mexico, this toad is the only known vertebrate that reliably produces 5‑MeO‑DMT in skin secretions. In humans 5‑MeO‑DMT can produce intense alterations of consciousness; in pets and predators the toxin can be paralytic or lethal—underscoring its defensive value. Researchers suspect the trait evolved via genetic changes or possibly through symbiosis with microbes. The species faces increasing pressure from collectors seeking its secretions, raising conservation and ethical concerns.
Fly agaric (Amanita muscaria)
The iconic red‑cap mushroom with white spots occurs across boreal and temperate forests from the U.K. to Siberia. It contains several psychoactive compounds—muscimol, muscarine, muscazone and ibotenic acid—whose effects differ from psilocybin. Ethnographic records link its ritual use to some Siberian shamanic practices, and some scholars have suggested it influenced northern folklore and imagery.
Ergot (Claviceps purpurea)
This parasitic fungus infects grasses and cereal crops—especially rye—and produces ergot alkaloids chemically related to lysergic compounds. High doses cause ergotism (St. Anthony’s fire), historically associated with burning pain, gangrene, convulsions and hallucinations. Ergot outbreaks in medieval Europe have been implicated in episodes of mass hysteria and strange social behaviors. In 1938 Albert Hofmann used ergot derivatives to synthesize LSD, which later became central to 20th‑century psychopharmacology.
Magic mushrooms (Psilocybe spp.)
About 200 species—mainly in the genus Psilocybe—produce psilocybin and psilocin and are commonly called “magic mushrooms.” These fungi thrive in humid, cool forests, river valleys and areas rich in decaying organic matter, and are well documented in the U.S., Mexico, Central America and Europe. Psilocybin is structurally similar to serotonin and other neuroregulators. Many psilocybin‑producing species favor disturbed or edge habitats—mulch beds, wood chips and grassy margins—making them more common near human settlements than people often expect. The tiny liberty cap (Psilocybe semilanceata) yields particularly potent natural doses.
Iboga (Tabernanthe iboga)
Native to Central African rainforests, Tabernanthe iboga concentrates the alkaloid ibogaine in its roots and bark. Ibogaine plays a central role in Bwiti spiritual rites—especially coming‑of‑age ceremonies—in parts of West Central Africa. Pharmacologically, ibogaine is long‑lasting and has been researched for treating opioid dependence, though it carries cardiac and other toxic risks at high doses.
Chacruna (Psychotria viridis) and ayahuasca
Psychotria viridis (chacruna) produces the tryptamine DMT. In traditional ayahuasca brews the DMT‑containing leaf is combined with the vine Banisteriopsis caapi, whose harmala alkaloids (harmine, harmaline) inhibit monoamine oxidase and allow DMT to act orally. Ayahuasca—often translated as “vine of the soul”—remains an important sacrament in Amazonian cultures and attracts international visitors seeking guided ceremonial experiences.
Yopo (Anadenanthera peregrina)
Anadenanthera peregrina grows in tropical savannas and semi‑deciduous forests of South America and some Caribbean islands. Its seeds have been used for millennia—dried, ground and insufflated as snuff—delivering compounds such as bufotenine, DMT and 5‑MeO‑DMT. Indigenous groups still use yopo in ritual contexts, and archaeological finds confirm ancient usage.
Across continents and biological kingdoms, evolution repeatedly converges on chemistry that alters perception. Whether serving defense, mutualism or another ecological function, these molecules have profoundly shaped human culture, religion and, increasingly, modern medicine. Responsible stewardship and respect for Indigenous knowledge are essential as interest in natural psychedelics grows.
Lead image credit: TorriPhoto / Shutterstock. This article synthesizes scientific, archaeological and ethnographic sources to summarize the distribution and roles of naturally occurring psychedelic compounds.
